Tender For SUPPLY OF TABLETS, INJECTIONS MISCELLANEOUS ITEMS, YEAR- 2026-27-28 Part 5(Item No1401 TO 1433)
Tender Overview
Project Description
SUPPLY OF TABLETS, INJECTIONS MISCELLANEOUS ITEMS, YEAR- 2026-27-28 Part 5(Item No1401 TO 1433)- triamcinolone injection 40 mg/ml (1 ml vial), triptorelin pamoate (11.25mg), triptorelin pamoate (22.5mg), trypan blue dye 0.06 percent w/v (1 ml oule), ultra long-acting basal insulin analogue inj (r-dna origin) insulin degludec 100iu/ml in 3ml pfs type of insulin:ultra long acting basa, vasopressin 20 units/ml, 1ml , vecuronium bromide injection 4 mg (iv use) (lyophilized), vedolizumab 300mg, velaglucerase alfa (r-dna origin), verapamil 10 mg, verapamil 5 mg/2 ml, vincristine sulphate lyophilized ip, vinorelbine concentrate, visco elastic substance (hydroxypropyl methyl cellulose ophthalmic solution usp) pfs 2.4 percent w/v 3 ml preservative free, vitamin b complex (for im use), 2 ml oule, vitamin b12 (mecobalamin) 1500 mcg/ml, vitamin b12 500 mcg/ml (cyanocobalamin injection), 1 ml oule, voriconazole 200mg/vial, zolendronic acid injection 4mg, human normal immunoglobulin and histamine dihydrochloride injection each ml contains:: - histamine dihydrochloride bp (0.15 mcg)- human normal immunoglobulin ip (12 mg)- sodium thiosulphate ip (32 mg)- water for injection ip (. qs)- stabilizer : maltose (in house) (7 percent )- pack sizes: 1ml in 2 ml vial /pfs- benzyl alcohol ip (1 percent ), human normal immunoglobulin i.p. 16.5 percent protein content (16.5 percent w/v)- stabilizer : glycine i.p. .. 0.3m (. )- preservative: thiomersal i.p. .... 0.01 percent w/v (. )- pack sizes: 1ml, 2ml and 5ml (. ), human prothrombin complex - 500 iu human prothrombin complex - 500 iu strength : each vial contains human coagulation factor ii - 280-760 iu human coagulation factor vii - 180 - 480 iu human coagulation factor ix - 500 iu human coagulation factor x -360 - 600 iu protein c - 260-620 iu protein s - 240-640 iupacking: vial, insulin glulisine prefillied pen, insulin glulisine cartrige, insulin glargine 300 iu/ml, human normal immunoglobulin and histamine dihydrochloride injection pfs each ml contains:: - histamine dihydrochloride bp (0.15 mcg)- human normal immunoglobulin ip (12 mg)- sodium thiosulphate ip (32 mg)- water for injection ip (. qs)- stabilizer : maltose (in house) (7 percent )- pack sizes: 1ml in 2 ml vial /pfs- benzyl alcohol ip (1 percent ) (2ml vial/pfs), human normal immunoglobulin i.p. 16.5 percent vial protein content (16.5 percent w/v)- stabilizer : glycine i.p. .. 0.3m (. )- preservative: thiomersal i.p. .... 0.01 percent w/v (. )- pack sizes: 1ml, 2ml and 5ml (. ) packing: vial, human prothrombin complex - 500 iu vialstrength : each vial contains human coagulation factor ii - 280-760 iu human coagulation factor vii - 180 - 480 iu human coagulation factor ix - 500 iu human coagulation factor x -360 - 600 iu protein c - 260-620 iu protein s - 240-640 iupacking: vial, anti hemophilic factor viii 250 iu (vwf) injection, anti hemophilic factor viii 500 iu (vwf) injection, anti hemophilic factor viii 1000 iu (vwf) injection, nafithromycin 400mg tab., nafithromycin 800mg tab.
BOQ
| Sl. No. | Item Name |
| 1 | triamcinolone injection 40 mg/ml (1 ml vial) |
| 2 | Triptorelin pamoate (11.25mg) |
| 3 | Triptorelin pamoate (22.5mg) |
| 4 | Trypan Blue Dye 0.06 Percent w/v (1 ml Ampoule) |
| 5 | Ultra long-acting Basal Insulin analogue inj (r-DNA origin) Insulin degludec 100iu/ml in 3ml PFS Type of Insulin:Ultra Long Acting Basa |
| 6 | Vasopressin 20 units/ml, 1ml Amp |
| 7 | Vecuronium Bromide Injection 4 mg (IV use) (Lyophilized) |
| 8 | Vedolizumab 300mg |
| 9 | Velaglucerase Alfa (r-DNA Origin) |
| 10 | Verapamil 10 mg |
| 11 | Verapamil 5 mg/2 ml |
| 12 | Vincristine sulphate lyophilized IP |
| 13 | Vinorelbine Concentrate |
| 14 | Visco Elastic substance (Hydroxypropyl Methyl Cellulose Ophthalmic Solution USP) PFS 2.4 Percent w/v 3 ml Preservative free |
| 15 | Vitamin B Complex (For IM Use), 2 ml Ampoule |
| 16 | Vitamin B12 (Mecobalamin) 1500 mcg/ml |
| 17 | Vitamin B12 500 mcg/ml (Cyanocobalamin Injection), 1 ml Ampoule |
| 18 | Voriconazole 200mg/vial |
| 19 | Zolendronic Acid Injection 4mg |
| 20 | Human Normal Immunoglobulin and Histamine Dihydrochloride Injection Each ml contains:: - Histamine Dihydrochloride BP (0.15 mcg)- Human Normal Immunoglobulin IP (12 mg)- Sodium Thiosulphate IP (32 mg)- Water for Injection IP (. QS)- Stabilizer : Maltose (In House) (7 Percent )- Pack sizes: 1ml in 2 ml Vial /pfs- Benzyl alcohol IP (1 Percent ) |
| 21 | Human Normal Immunoglobulin I.P. 16.5 Percent Protein Content (16.5 Percent W/V)- Stabilizer : Glycine I.P. .. 0.3M (. )- Preservative: Thiomersal I.P. .... 0.01 Percent w/v (. )- Pack Sizes: 1ml, 2ml and 5ml (. ) |
| 22 | Human Prothrombin Complex - 500 IU Human Prothrombin Complex - 500 IU Strength : Each Vial Contains Human Coagulation Factor II - 280-760 IU Human Coagulation Factor VII - 180 - 480 IU Human Coagulation Factor IX - 500 IU Human Coagulation Factor X -360 - 600 IU Protein C - 260-620 IU Protein S - 240-640 IUPacking: Vial |
| 23 | Insulin Glulisine Prefillied Pen |
| 24 | Insulin Glulisine Cartrige |
| 25 | Insulin Glargine 300 IU/ml |
| 26 | Human Normal Immunoglobulin and Histamine Dihydrochloride Injection PFS Each ml contains:: - Histamine Dihydrochloride BP (0.15 mcg)- Human Normal Immunoglobulin IP (12 mg)- Sodium Thiosulphate IP (32 mg)- Water for Injection IP (. QS)- Stabilizer : Maltose (In House) (7 Percent )- Pack sizes: 1ml in 2 ml Vial /pfs- Benzyl alcohol IP (1 Percent ) (2ml Vial/PFS) |
| 27 | Human Normal Immunoglobulin I.P. 16.5 Percent Vial Protein Content (16.5 Percent W/V)- Stabilizer : Glycine I.P. .. 0.3M (. )- Preservative: Thiomersal I.P. .... 0.01 Percent w/v (. )- Pack Sizes: 1ml, 2ml and 5ml (. ) Packing: Vial |
| 28 | Human Prothrombin Complex - 500 IU VialStrength : Each Vial Contains Human Coagulation Factor II - 280-760 IU Human Coagulation Factor VII - 180 - 480 IU Human Coagulation Factor IX - 500 IU Human Coagulation Factor X -360 - 600 IU Protein C - 260-620 IU Protein S - 240-640 IUPacking: Vial |
| 29 | Anti Hemophilic Factor VIII 250 IU (VWF) Injection |
| 30 | Anti Hemophilic Factor VIII 500 IU (VWF) Injection |
| 31 | Anti Hemophilic Factor VIII 1000 IU (VWF) Injection |
| 32 | Nafithromycin 400mg Tab. |
| 33 | Nafithromycin 800mg Tab. |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 12 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender